Physician profile
Irene Olabode
NPI 1619297744
$1,252.26
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,230 · 2020: $21.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $144.39 | 2019 | |
| Amgen INC. | $119.22 | 2019 | |
| Merck Sharp & Dohme LLC | $117.16 | 2019 | |
| Amarin Pharma, INC. | $104.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $98.16 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $86.14 | 2019 | |
| Novartis Pharmaceuticals Corporation | $70.99 | 2019 | |
| Astellas Pharma US INC | $69.57 | 2019 | |
| Pfizer INC. | $69.08 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.88 | 2019 | |
| Arbor Pharmaceuticals, INC. | $56.34 | 2019 | |
| Glaxosmithkline, LLC. | $48.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.17 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $29.45 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.44 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.48 | 2019 | |
| Hologic Sales and Service, LLC | $21.99 | 2020 | |
| Neotract INC. | $13.87 | 2019 | |
| Lilly USA, LLC | $13.21 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Olabode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.